Search clinical trials for: Ciliary Neurotrophic Factor Implant NT-501
Total 18 results
-
National Eye Institute (NEI)CompletedRetinitis PigmentosaUnited States
-
Neurotech PharmaceuticalsThe Emmes Company, LLC; The Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
Neurotech PharmaceuticalsCompletedMacular TelangiectasiaUnited States, Australia
-
Neurotech PharmaceuticalsCompletedRetinitis PigmentosaUnited States
-
Jeffrey L GoldbergCompletedIschemic Optic Neuropathy/Optic Nerve StrokeUnited States
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
Neurotech PharmaceuticalsCompletedRetinitis PigmentosaUnited States
-
Jeffrey L GoldbergCompletedGlaucoma, Primary Open AngleUnited States
-
Neurotech PharmaceuticalsNot yet recruitingMacular Telangiectasia Type 2United States
-
National Eye Institute (NEI)Completed
-
Neurotech PharmaceuticalsCompletedMacular DegenerationUnited States
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedCompletedIdiopathic Juxtafoveal TelangiectasiaUnited States
-
Stanford UniversityActive, not recruiting
-
InnocollMedpace, Inc.Completed
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Therapy-Related Acute Myeloid Leukemia and other conditionsUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaUnited States